Trial Profile
Primary Chemotherapy With Temozolomide Versus Radiotherapy in Patients With Low Grade Gliomas After Stratification for Genetic 1p Loss: A Phase III Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Jan 2022
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Astrocytoma; Glioma; Oligodendroglioma
- Focus Therapeutic Use
- 19 Jan 2022 This trial has been completed in Greece, according to European Clinical Trials Database
- 18 Dec 2021 This trial has been completed in Portugal, according to European Clinical Trials Database.
- 18 Dec 2021 This trial has been completed in Italy, according to European Clinical Trials Database.